Oncology
Epeius tumor targeting platforms enable precision targeting of genetic medicine and cancer vaccines. Rexin-G™ delivers a cytocidal designer gene that is highly active against a broad spectrum of chemo-resistant cancers. Reximmune-C™ delivers the GM-CSF gene that enables individualized vaccination of a patient against his or her specific type of cancer.